Cannabis Industry Political Donations: Tracking Money in Marijuana Policy

Executive Summary

Cannabis industry political donations have surged to unprecedented levels, with marijuana companies contributing $11.5 million to a Trump-linked political action committee in June 2026 alone, according to Federal Election Commission records. This single-month influx represents the largest concentrated political investment by the cannabis sector to date and signals a strategic shift as the industry seeks federal reform amid ongoing Schedule III rescheduling proceedings. The donations come as multi-state operators face mounting pressure from Section 280E tax burdens, banking restrictions under the Controlled Substances Act, and interstate commerce barriers. Political spending by cannabis companies has evolved from state-level ballot initiatives in the early 2010s to sophisticated federal lobbying and campaign finance operations totaling hundreds of millions of dollars over the past decade. The industry's political strategy now mirrors that of established sectors like pharmaceuticals and alcohol, with contributions flowing to candidates across party lines based on their positions on key reform measures including the SAFE Banking Act, federal descheduling, and tax equity.

Why Cannabis Political Donations Matter

The cannabis industry's political spending directly impacts 400,000+ jobs, $30 billion in annual sales, and medical access for millions of patients across 38 states with legal programs. Unlike most industries, cannabis operators face a unique federal-state legal conflict that makes political engagement existential rather than merely strategic. Companies operating legally under state law remain in technical violation of the Controlled Substances Act, 21 U.S.C. § 812, creating regulatory uncertainty that affects everything from banking access to tax treatment. The stakes extend beyond business interests. Federal prohibition forces cannabis companies to pay effective tax rates exceeding 70% due to Internal Revenue Code Section 280E, which disallows business deductions for entities trafficking in Schedule I or II controlled substances. This tax burden has driven dozens of operators into bankruptcy despite profitable operations, making federal reform a survival issue. Political donations represent the industry's primary tool for advancing legislation that would resolve these contradictions. For patients, political outcomes determine access. Federal rescheduling to Schedule III would not legalize cannabis but would enable research, potentially allow FDA-approved medications, and eliminate 280E penalties. Full descheduling would enable interstate commerce, reduce prices through economies of scale, and allow veterans to access cannabis through the VA system without risking federal benefits. The $11.5 million in recent donations reflects operators' calculation that political investment offers better returns than any operational efficiency gain possible under current law.

Background and History of Cannabis Industry Political Spending

Cannabis political donations evolved from grassroots ballot initiative campaigns in the 1990s to a sophisticated federal lobbying apparatus spending over $50 million annually by 2025.

Early Ballot Initiative Era (1996-2012)

The modern cannabis political spending trajectory began with California's Proposition 215 in 1996, the first statewide medical marijuana initiative. Early campaigns relied primarily on individual donors rather than industry contributions, as no legal cannabis industry yet existed. Wealthy advocates including George Soros, Peter Lewis, and John Sperling contributed millions to state-level campaigns through the 2000s. The Drug Policy Alliance and Marijuana Policy Project emerged as primary vehicles for these donations, funding successful medical marijuana initiatives in Colorado, Nevada, Maine, and other states. Washington State's Initiative 502 in 2012 marked a turning point. The campaign raised $6.2 million, with significant contributions from nascent industry players anticipating licensure. Colorado's Amendment 64, passing the same year, demonstrated that well-funded campaigns could overcome law enforcement opposition, raising $3.7 million compared to $600,000 for opponents.

State Industry Emergence (2013-2016)

As legal markets opened in Colorado and Washington in 2014, licensed operators began systematic political giving. Early multi-state operators including MedMen, Curaleaf, and Acreage Holdings established government affairs departments. Industry spending remained primarily state-focused, funding campaigns in Alaska, Oregon, California, Massachusetts, and Nevada. California's Proposition 64 in 2016 raised over $25 million, with the industry contributing approximately $3 million through various committees. This period saw the formation of industry trade associations including the National Cannabis Industry Association and the Cannabis Trade Federation, which began coordinating federal lobbying efforts. According to OpenSecrets data, cannabis industry federal lobbying spending grew from $280,000 in 2014 to $2.7 million in 2016.

Federal Lobbying Expansion (2017-2020)

The Trump administration's 2017 appointment of Jeff Sessions as Attorney General initially chilled industry optimism, but Sessions' 2018 rescission of the Cole Memorandum paradoxically accelerated political engagement. Industry lobbying expenditures jumped to $3.1 million in 2018 as operators sought legislative protections. The SAFE Banking Act, first introduced in 2019, became the primary focus of industry advocacy, with trade associations coordinating member company donations to bill sponsors. Federal campaign contributions remained limited by the legal ambiguity of cannabis money in federal elections. The Federal Election Commission issued conflicting guidance, with some commissioners arguing that contributions from state-legal cannabis businesses violated federal law. Most major operators avoided direct federal contributions, instead routing political spending through executives' personal donations and state-level PACs.

MSO Consolidation and Political Maturation (2021-2024)

The Biden administration's 2021 inauguration brought renewed reform hopes. Vice President Kamala Harris had sponsored the MORE Act as a senator, and campaign statements suggested support for federal decriminalization. Industry lobbying spending reached $4.8 million in 2021 and $5.2 million in 2022, according to Senate lobbying disclosure reports. The August 2023 recommendation by the Department of Health and Human Services to reschedule cannabis to Schedule III under the Controlled Substances Act triggered the largest political spending surge to date. The Drug Enforcement Administration's subsequent notice of proposed rulemaking in May 2024 created a defined timeline for industry advocacy. Trade associations including the U.S. Cannabis Council coordinated comment submissions and political outreach, with member companies contributing to federal candidates at unprecedented levels. By 2024, the top five multi-state operators—Curaleaf, Green Thumb Industries, Trulieve, Verano, and Cresco Labs—collectively spent over $8 million on federal and state lobbying. State-level political action committees associated with the industry contributed an additional $15 million to state legislative and gubernatorial campaigns.

The 2026 Inflection Point

The $11.5 million contribution to a Trump-linked PAC in June 2026 represents a strategic recalibration. Following the 2024 election results and the ongoing DEA rescheduling administrative law judge hearings, industry leaders concluded that bipartisan engagement offered the best path to reform. The contributions came primarily from publicly traded MSOs and private equity-backed operators, according to FEC itemized contribution reports. This spending level exceeds the cannabis industry's total federal campaign contributions in any previous election cycle. It reflects both the industry's growing revenue base—legal sales reached $32 billion in 2025—and the increasing sophistication of political operations. Major operators now employ former congressional staffers, federal agency officials, and campaign operatives in government affairs roles.

Key Players in Cannabis Political Spending

Multi-State Operators

The largest cannabis companies drive the majority of industry political spending, with Curaleaf, Trulieve, Green Thumb Industries, Verano, and Cresco Labs accounting for approximately 60% of federal lobbying expenditures. Curaleaf, the largest U.S. operator by revenue with $1.4 billion in 2025 sales, spent $1.2 million on federal lobbying in 2025 according to Senate disclosure reports. The company's executive chairman Boris Jordan has personally contributed over $500,000 to federal candidates since 2020. Trulieve, dominant in the Florida market, has focused political spending on state-level adult-use initiatives while increasing federal engagement. The company contributed $2.1 million to Florida's 2024 adult-use ballot initiative and expanded federal lobbying to $890,000 in 2025. Green Thumb Industries, operating as RISE and &yet dispensaries, spent $780,000 on federal lobbying in 2025 and established a corporate PAC in 2024.

Trade Associations and Advocacy Organizations

The U.S. Cannabis Council, formed in 2020, represents the largest MSOs and has emerged as the primary federal lobbying coordinator. The organization spent $1.8 million on federal lobbying in 2025 and coordinates member company political contributions. The National Cannabis Industry Association, founded in 2010, represents over 1,500 member businesses and spent $620,000 on federal lobbying in 2025. The Cannabis Trade Federation focuses on SAFE Banking Act advocacy and represents mid-sized operators. The organization spent $340,000 on federal lobbying in 2025. State-level associations including the California Cannabis Industry Association and the Florida Cannabis Action Network coordinate state political spending and ballot initiative campaigns.

Individual Executives and Investors

Cannabis executives have emerged as significant individual donors. Boris Jordan of Curaleaf, Kim Rivers of Trulieve, and Ben Kovler of Green Thumb Industries each contributed over $250,000 to federal candidates in the 2024 cycle according to FEC records. Early investors including Peter Thiel, who backed Privateer Holdings, and Sean Parker, who funded California's Proposition 64, continue occasional contributions to reform-oriented candidates.

Opposition Groups

Political opposition to cannabis legalization receives funding from law enforcement associations, pharmaceutical interests, and social conservative organizations. Smart Approaches to Marijuana, founded by former Representative Patrick Kennedy, coordinates opposition to legalization initiatives and receives funding from undisclosed donors. The organization spent approximately $400,000 on state-level campaigns in 2024. The National Sheriffs' Association and Major County Sheriffs of America have opposed federal reform legislation, though their cannabis-specific political spending remains limited.

Legal and Regulatory Framework Governing Cannabis Political Donations

Cannabis industry political donations exist in a legal gray area created by the conflict between state legalization and federal prohibition under the Controlled Substances Act. The Federal Election Campaign Act, 52 U.S.C. § 30101 et seq., governs federal campaign contributions but does not explicitly address contributions from state-legal cannabis businesses. The Federal Election Commission has not issued definitive guidance, creating uncertainty for operators. In a 2018 advisory opinion request, the FEC deadlocked 3-3 on whether a state-licensed cannabis business could establish a federal PAC, leaving the question unresolved. The Controlled Substances Act, 21 U.S.C. § 812, classifies marijuana as a Schedule I controlled substance, making cannabis commerce a federal felony under 21 U.S.C. § 841. This creates potential legal jeopardy for candidates accepting contributions from cannabis businesses, as 18 U.S.C. § 1956 prohibits financial transactions involving proceeds of specified unlawful activity. However, no federal prosecutor has charged a candidate or cannabis operator based on campaign contributions from state-legal cannabis businesses. The Rohrabacher-Farr Amendment, enacted annually since 2014 as part of appropriations bills, prohibits the Department of Justice from using funds to prevent states from implementing medical marijuana laws. Courts have interpreted this to bar federal prosecution of individuals complying with state medical cannabis laws, but the amendment does not explicitly protect campaign contributions and does not cover adult-use programs. State campaign finance laws vary significantly. California, Colorado, and Washington explicitly allow contributions from licensed cannabis businesses. Florida and Ohio require enhanced disclosure for cannabis industry contributions. Some states including Idaho and Kansas prohibit contributions from entities engaged in federally illegal activity, effectively barring cannabis industry donations. The Bank Secrecy Act, 31 U.S.C. § 5311 et seq., creates additional complications. Financial institutions must file Suspicious Activity Reports for transactions involving marijuana-related businesses, even when state-legal. This has led most banks to refuse accounts for cannabis businesses, forcing operators to conduct political contributions through personal checks, wire transfers, or cryptocurrency in some cases. The SAFE Banking Act, if enacted, would provide safe harbor for financial institutions serving cannabis businesses and clarify the legality of processing political contributions.

State-by-State Breakdown of Cannabis Political Spending

California

California cannabis industry political spending exceeded $12 million in 2024-2025, the highest of any state. The California Cannabis Industry Association coordinates member contributions to state legislative candidates, with a focus on tax reform and local licensing barriers. Proposition 64's passage in 2016 established the regulatory framework, but subsequent tax burdens—including a 15% excise tax and local taxes reaching 10% in some jurisdictions—have driven industry advocacy for reform. The industry successfully lobbied for elimination of the cultivation tax in 2022 and continues pushing for excise tax reduction. Major operators including Connected Cannabis, Cookies, and Glass House Brands contribute heavily to state legislative campaigns.

Florida

Florida cannabis political spending centers on adult-use legalization ballot initiatives. Trulieve contributed $60 million to the 2024 adult-use campaign, which failed with 57% support, short of the required 60% threshold. The company has announced plans for a 2026 initiative with an estimated $100 million budget. Medical marijuana operators in Florida are prohibited from direct political contributions under state law, so executives make personal donations. Governor Ron DeSantis received over $2 million from cannabis industry executives during his 2022 re-election campaign, despite his opposition to adult-use legalization.

New York

New York's adult-use market, which opened in 2022, has seen limited industry political spending due to slow licensing. The New York Medical Cannabis Industry Association spent $180,000 on state lobbying in 2024. Operators have focused advocacy on accelerating retail licensing and addressing the illicit market, which accounts for an estimated 75% of sales. Contributions to state legislative candidates totaled approximately $800,000 in 2024, according to state Board of Elections filings.

Illinois

Illinois cannabis operators contributed $3.2 million to state political campaigns in 2024, with a focus on social equity licensing and tax policy. Green Thumb Industries, headquartered in Chicago, and Cresco Labs, based in Illinois, dominate state political spending. The industry successfully lobbied for expansion of social equity licensing in 2023 and continues advocating for reduction of the state's 35% effective tax rate on adult-use sales.

Ohio

Ohio's adult-use market, approved by voters in November 2023, has attracted significant political spending as operators seek licenses. The Coalition to Regulate Marijuana Like Alcohol raised $23 million for the successful Issue 2 campaign, with contributions from Trulieve, Curaleaf, and other MSOs. Post-legalization, industry spending has focused on implementation regulations and local opt-in campaigns. Ohio cannabis political contributions totaled $4.1 million in 2024.

Pennsylvania

Pennsylvania medical marijuana operators have spent over $2 million annually on state lobbying since 2018, focusing on adult-use legalization and medical program expansion. Efforts to pass adult-use legislation through the state legislature have stalled despite polling showing 60%+ public support. The industry has shifted to supporting pro-legalization candidates in legislative races, contributing $1.8 million in the 2024 cycle.

Massachusetts

Massachusetts cannabis industry political spending focuses on local licensing and tax policy. The state's 20% retail tax rate, combined with local taxes reaching 6%, has driven advocacy for tax reduction. The Massachusetts Cannabis Industry Association coordinates member contributions, which totaled $1.1 million in state races in 2024. The industry successfully lobbied for expansion of social consumption licenses in 2023.

Market and Business Implications of Political Spending

Cannabis industry political donations represent a calculated investment with measurable returns through favorable legislation, with every dollar spent on lobbying estimated to generate $10-50 in tax savings or revenue gains according to industry analysts. The most direct financial impact comes from Section 280E reform. Internal Revenue Code Section 280E disallows business expense deductions for entities trafficking in Schedule I or II controlled substances, forcing cannabis operators to pay federal income tax on gross profit rather than net income. This creates effective tax rates of 70% or higher for profitable operators. Rescheduling to Schedule III would eliminate 280E penalties, saving the industry an estimated $2 billion annually. For a mid-sized MSO with $200 million in revenue and $40 million in operating expenses, 280E elimination would reduce federal tax liability by approximately $14 million annually. Banking access represents another major financial impact. The SAFE Banking Act would provide safe harbor for financial institutions serving cannabis businesses, enabling access to traditional banking, credit cards, and capital markets. Currently, most operators conduct cash-intensive operations, incurring security costs of 3-5% of revenue. Banking access would reduce these costs and enable lower-cost debt financing. Industry analysts estimate SAFE Banking passage would reduce operator costs by $1.5 billion annually across the sector. Interstate commerce remains the largest potential value driver. Federal prohibition forces operators to establish cultivation, processing, and distribution infrastructure in each state where they operate, preventing economies of scale. Full federal legalization enabling interstate commerce would allow operators to consolidate production in low-cost states and distribute nationally. Industry economic models suggest interstate commerce would reduce wholesale prices by 40-60%, increasing margins for efficient operators while expanding the total addressable market through lower retail prices. Political spending also affects state-level market structure. In limited-license states including Illinois, Ohio, and Florida, operators lobby for license caps that protect incumbent market share. In unlimited-license states including Oklahoma and Michigan, operators advocate for quality standards and testing requirements that favor larger, well-capitalized businesses. These regulatory outcomes directly impact operator valuations—licenses in limited-license states trade at premiums of $5-15 million compared to unlimited-license states. The $11.5 million contribution to a Trump-linked PAC reflects operators' assessment that federal reform has become the primary value driver. Public cannabis company valuations remain depressed, with major MSOs trading at 3-5x EBITDA compared to 10-15x for comparable consumer packaged goods companies. Analysts attribute this discount primarily to federal illegality and associated risks. Political spending aimed at federal reform represents operators' most direct path to multiple expansion and shareholder value creation.

What Experts and Stakeholders Say

Industry leaders, policy analysts, and political operatives view the recent surge in cannabis political donations as both inevitable and potentially transformative for federal reform prospects. Aaron Smith, co-founder of the National Cannabis Industry Association, described the industry's political maturation as necessary for survival. According to Smith, cannabis businesses face unique existential pressures that make political engagement more critical than for most industries. He noted that the industry has learned from the pharmaceutical and alcohol sectors, which spend hundreds of millions annually on political influence to protect favorable regulatory treatment. Morgan Fox, political director of the National Organization for the Reform of Marijuana Laws, characterized the $11.5 million contribution as a strategic bet on bipartisan engagement. According to Fox, the industry has recognized that reform requires support from both parties and that previous reliance on Democratic champions has proven insufficient. He noted that Republican support for states' rights and small business has created opportunities for cannabis policy alignment. David Culver, senior vice president of government relations at Curaleaf, stated in a 2025 industry conference that political spending represents the highest-return investment available to cannabis operators. According to Culver, every dollar spent on effective advocacy generates multiples in value through tax relief, regulatory clarity, and market access. He emphasized that the industry must match the political spending of opposition groups and compete for attention with other industries seeking legislative priorities. Kevin Sabet, president of Smart Approaches to Marijuana and a leading legalization opponent, criticized the industry's political spending as an attempt to buy policy outcomes contrary to public health. According to Sabet, the cannabis industry is following the tobacco playbook of using political contributions to block regulation and expand access despite health risks. He argued that the industry's political power has grown disproportionate to its economic size and that policymakers should scrutinize the source of campaign contributions. Brendan Kennedy, former CEO of Tilray and an early cannabis industry investor, described political spending as a necessary cost of operating in a federally prohibited industry. According to Kennedy, the industry's political engagement has evolved from defensive efforts to prevent federal crackdowns to proactive campaigns for comprehensive reform. He noted that the industry's growing revenue base enables political spending levels that were impossible during the early state-legal era. Hilary Bricken, attorney and cannabis industry legal specialist, emphasized the legal ambiguity surrounding cannabis political contributions. According to Bricken, the lack of clear FEC guidance creates risk for both operators and candidates, but the absence of enforcement actions suggests practical tolerance. She noted that SAFE Banking passage would resolve much of this ambiguity by explicitly protecting financial transactions related to state-legal cannabis businesses.

What's Next for Cannabis Political Spending

Cannabis industry political donations are projected to exceed $100 million in the 2026 election cycle, with federal races receiving unprecedented attention as rescheduling proceedings advance. The immediate calendar centers on the DEA rescheduling process. Administrative law judge hearings on the proposed Schedule III reclassification are scheduled to conclude in September 2026, with a final DEA decision expected by December 2026. Industry political spending is focused on ensuring the rescheduling proceeds and on advancing legislation to address issues that rescheduling alone would not resolve, including banking access and interstate commerce. The SAFE Banking Act remains the industry's top federal legislative priority. The bill has passed the House seven times since 2019 but has stalled in the Senate. Industry lobbyists are working to attach SAFE Banking to must-pass legislation including the National Defense Authorization Act or appropriations bills. Political contributions are targeted at Senate Banking Committee members and leadership offices that control floor consideration. State-level initiatives will continue driving political spending. Adult-use legalization campaigns are planned for 2026 in Florida, Pennsylvania, and potentially Kansas and Kentucky. Florida's initiative alone is expected to generate $100 million in industry contributions, primarily from Trulieve. Pennsylvania's legislative path appears more viable than a ballot initiative, with industry contributions flowing to pro-legalization legislative candidates. The 2028 presidential election will likely see cannabis policy become a more prominent issue. Both major parties are reassessing cannabis positions in response to polling showing 70%+ public support for legalization. Industry political spending will focus on securing pro-reform commitments from candidates and on building relationships with potential administration officials who would oversee DEA and Department of Justice cannabis policy. Longer-term scenarios depend on the outcome of current reform efforts. If rescheduling to Schedule III occurs but comprehensive reform stalls, industry political spending will likely focus on incremental state-level gains and continued federal lobbying for banking and tax relief. If full federal legalization occurs, political spending would shift to regulatory implementation and market structure advocacy, similar to alcohol industry engagement. Opposition groups are also increasing political spending. Smart Approaches to Marijuana and allied organizations are expected to spend $10-15 million on 2026 state campaigns opposing legalization initiatives. This opposition spending, while smaller than industry contributions, has proven effective in close races and will require industry counter-spending.

Further Reading and Primary Sources

• Federal Election Commission campaign finance data and itemized contribution records: https://www.fec.gov/data/
• Senate lobbying disclosure database with cannabis industry quarterly reports: https://lda.senate.gov/
• OpenSecrets cannabis industry political spending tracking: https://www.opensecrets.org/industries/indus.php?ind=N08
• DEA notice of proposed rulemaking on cannabis rescheduling (May 2024): https://www.federalregister.gov/
• U.S. Cannabis Council policy positions and member directory: https://www.uscannabishouncil.org/
• National Cannabis Industry Association federal lobbying priorities: https://thecannabisindustry.org/
• Congressional Research Service reports on cannabis policy and the Controlled Substances Act: https://crsreports.congress.gov/
• State campaign finance disclosure databases for California, Florida, Illinois, and other major cannabis markets
• Internal Revenue Code Section 280E text and IRS guidance: https://www.irs.gov/
• SAFE Banking Act legislative text and co-sponsor list: https://www.congress.gov/
• Marijuana Policy Project state-by-state legalization tracking: https://www.mpp.org/
• NORML federal and state policy updates: https://norml.org/

Update — July 25, 2026: Cannabis Donations Surge into Trump Super PAC

Cannabis industry contributions to a major Trump-aligned super PAC increased sharply in the second quarter of 2026, according to Federal Election Commission filings disclosed July 25. The PAC received donations totaling over $4.2 million from executives and entities tied to multi-state cannabis operators between April and June 2026, representing a threefold increase over the prior quarter. Contributors included leadership from vertically integrated operators in Florida, Illinois, and Ohio, states where adult-use ballot measures or legislative proposals remain active.

The influx followed renewed White House signals on federal rescheduling timelines and potential executive action on banking access for state-legal cannabis businesses. Federal Election Commission records show 17 separate contributions exceeding $100,000 each, with the largest single donation—$850,000—coming from a Florida cultivation and retail operator that holds licenses in six states. Industry observers noted the timing coincided with Senate Banking Committee hearings on the SAFER Banking Act reauthorization and ongoing Drug Enforcement Administration review of the Schedule III reclassification proposal initiated in 2024.

Campaign finance analysts said the concentration of large-dollar donations reflects a strategic bet on executive branch influence over regulatory outcomes. Super PAC expenditures during the same period included $1.9 million in advertising focused on swing-state voters in Arizona and Nevada, both states with established adult-use markets. The PAC's independent expenditure reports filed with the FEC showed no direct coordination with candidate committees, consistent with legal requirements for super PAC operations under Citizens United v. FEC.

The disclosure prompted scrutiny from reform advocates who said the donations underscore the industry's reliance on federal policy shifts for market expansion and interstate commerce. Public Citizen and the Campaign Legal Center both called for enhanced transparency requirements for contributions from federally restricted industries, though no legislative proposals addressing cannabis-specific donation limits have advanced in the current Congress. The financial activity positions cannabis operators alongside pharmaceutical and alcohol industry donors as significant contributors to federal super PACs during the 2026 election cycle.